From: Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Grade 1–2 | Grade 3–4 | |||||
---|---|---|---|---|---|---|
On Pz (No.) | NO Pz (No.) | Total (No.) | On Pz (No.) | NO Pz (No.) | Total (No.) | |
Hematologic | ||||||
Anemia | 3 | 1 | 4 | – | – | – |
Neutropenia | 1 | – | 1 | – | – | – |
Thrombocytopenia | 1 | 1 | 2 | – | – | – |
Non-hematologic | ||||||
Diarrhea | 3 | 3 | 1 | 1 | ||
Pneumonitis | 1 | 1 | 1 | 1 | ||
Rash | 3 | 1 | 4 | – | – | – |
Hypothyroidism | 6 | 2 | 8 | – | – | – |
LFTs | 8 | 2 | 10 | 3 | 3 |